# Core Molding Technologies Inc: financial statements, quarterly

CMT · NYSE · CIK 1026655 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cmt.md) · [Financials](/companies/cmt/financials.md) · [Filings](/companies/cmt/filings.md) · [Insiders](/companies/cmt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cmt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [86.7](/filings/0001026655-26-000009.md) | [73.8](/filings/0001026655-26-000009.md) | [78.1](/filings/0001026655-26-000009.md) | [88.7](/filings/0001026655-26-000009.md) | [73.0](/filings/0001026655-26-000009.md) | [62.5](/filings/0001026655-26-000009.md) | [61.4](/filings/0001026655-26-000028.md) | [79.2](/filings/0001026655-26-000053.md) | [58.4](/filings/0001026655-26-000009.md) | [74.7](/filings/0001026655-26-000009.md) | [58.6](/filings/0001026655-26-000028.md) | [62.7](/filings/0001026655-26-000053.md) |
| Cost of revenue | $m | [71.5](/filings/0001026655-24-000132.md) | [62.8 d](/filings/0001026655-26-000009.md) | [64.8](/filings/0001026655-25-000030.md) | [71.0](/filings/0001026655-25-000071.md) | [60.6](/filings/0001026655-25-000085.md) | [52.6 d](/filings/0001026655-26-000009.md) | [49.7](/filings/0001026655-26-000028.md) | [64.9](/filings/0001026655-26-000053.md) | [48.3](/filings/0001026655-25-000085.md) | [63.3 d](/filings/0001026655-26-000009.md) | [46.6](/filings/0001026655-26-000028.md) | [50.0](/filings/0001026655-26-000053.md) |
| Gross profit | $m | [15.3](/filings/0001026655-26-000009.md) | [10.9](/filings/0001026655-26-000009.md) | [13.3](/filings/0001026655-26-000009.md) | [17.7](/filings/0001026655-26-000009.md) | [12.3](/filings/0001026655-26-000009.md) | [9.9](/filings/0001026655-26-000009.md) | [11.8](/filings/0001026655-26-000028.md) | [14.3](/filings/0001026655-26-000053.md) | [10.1](/filings/0001026655-26-000009.md) | [11.3](/filings/0001026655-26-000009.md) | [12.0](/filings/0001026655-26-000028.md) | [12.7](/filings/0001026655-26-000053.md) |
| Selling, general and administrative | $m | [9.4](/filings/0001026655-24-000132.md) | [8.4 d](/filings/0001026655-26-000009.md) | [8.6](/filings/0001026655-25-000030.md) | [10.2](/filings/0001026655-25-000071.md) | [8.7](/filings/0001026655-25-000085.md) | [9.0 d](/filings/0001026655-26-000009.md) | [8.9](/filings/0001026655-26-000028.md) | [9.1](/filings/0001026655-26-000053.md) | [7.6](/filings/0001026655-25-000085.md) | [7.7 d](/filings/0001026655-26-000009.md) | [11.2](/filings/0001026655-26-000028.md) | [10.4](/filings/0001026655-26-000053.md) |
| Operating income | $m | [5.9](/filings/0001026655-26-000009.md) | [2.5](/filings/0001026655-26-000009.md) | [4.7](/filings/0001026655-26-000009.md) | [7.5](/filings/0001026655-26-000009.md) | [3.6](/filings/0001026655-26-000009.md) | [0.9](/filings/0001026655-26-000009.md) | [2.8](/filings/0001026655-26-000028.md) | [5.2](/filings/0001026655-26-000053.md) | [2.6](/filings/0001026655-26-000009.md) | [3.6](/filings/0001026655-26-000009.md) | [0.8](/filings/0001026655-26-000028.md) | [2.3](/filings/0001026655-26-000053.md) |
| Interest expense | $m | [0.2](/filings/0001026655-24-000132.md) | [0.2 d](/filings/0001026655-26-000009.md) | [0.1](/filings/0001026655-25-000030.md) | [(0.0)](/filings/0001026655-25-000071.md) | [(0.1)](/filings/0001026655-25-000085.md) | [(0.1) d](/filings/0001026655-26-000009.md) | [0.0](/filings/0001026655-26-000028.md) | [(0.0)](/filings/0001026655-26-000053.md) | [0.0](/filings/0001026655-25-000085.md) | [(0.0) d](/filings/0001026655-26-000009.md) | [0.1](/filings/0001026655-26-000028.md) | [0.1](/filings/0001026655-26-000053.md) |
| Income tax | $m | [1.4](/filings/0001026655-24-000132.md) | [0.2 d](/filings/0001026655-26-000009.md) | [1.0](/filings/0001026655-25-000030.md) | [1.2](/filings/0001026655-25-000071.md) | [0.7](/filings/0001026655-25-000085.md) | [1.2 d](/filings/0001026655-26-000009.md) | [0.8](/filings/0001026655-26-000028.md) | [1.3](/filings/0001026655-26-000053.md) | [0.8](/filings/0001026655-25-000085.md) | [0.6 d](/filings/0001026655-26-000009.md) | [0.2](/filings/0001026655-26-000028.md) | [0.6](/filings/0001026655-26-000053.md) |
| Net income | $m | [4.4](/filings/0001026655-26-000009.md) | [2.2](/filings/0001026655-26-000009.md) | [3.8](/filings/0001026655-26-000009.md) | [6.4](/filings/0001026655-26-000009.md) | [3.2](/filings/0001026655-26-000009.md) | [(0.0)](/filings/0001026655-26-000009.md) | [2.2](/filings/0001026655-26-000028.md) | [4.1](/filings/0001026655-26-000053.md) | [1.9](/filings/0001026655-26-000009.md) | [3.1](/filings/0001026655-26-000009.md) | [0.6](/filings/0001026655-26-000028.md) | [1.8](/filings/0001026655-26-000053.md) |
| Diluted EPS | $ per share | [0.49](/filings/0001026655-26-000009.md) | [0.25](/filings/0001026655-26-000009.md) | [0.43](/filings/0001026655-26-000009.md) | [0.73](/filings/0001026655-26-000009.md) | [0.36](/filings/0001026655-26-000009.md) | [0.00](/filings/0001026655-26-000009.md) | [0.25](/filings/0001026655-26-000028.md) | [0.47](/filings/0001026655-26-000053.md) | [0.22](/filings/0001026655-26-000009.md) | [0.36](/filings/0001026655-26-000009.md) | [0.07](/filings/0001026655-26-000028.md) | [0.21](/filings/0001026655-26-000053.md) |
| Basic EPS | $ per share | [0.50](/filings/0001026655-26-000009.md) | [0.25](/filings/0001026655-26-000009.md) | [0.43](/filings/0001026655-26-000009.md) | [0.74](/filings/0001026655-26-000009.md) | [0.36](/filings/0001026655-26-000009.md) | [0.00](/filings/0001026655-26-000009.md) | [0.25](/filings/0001026655-26-000028.md) | [0.47](/filings/0001026655-26-000053.md) | [0.22](/filings/0001026655-26-000009.md) | [0.36](/filings/0001026655-26-000009.md) | [0.07](/filings/0001026655-26-000028.md) | [0.21](/filings/0001026655-26-000053.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [18.0](/filings/0001026655-23-000188.md) | [24.1](/filings/0001026655-25-000005.md) | [26.6](/filings/0001026655-24-000059.md) | [37.8](/filings/0001026655-24-000097.md) | [42.3](/filings/0001026655-24-000132.md) | [41.8](/filings/0001026655-26-000009.md) | [44.5](/filings/0001026655-25-000030.md) | [43.2](/filings/0001026655-25-000071.md) | [42.4](/filings/0001026655-25-000085.md) | [38.1](/filings/0001026655-26-000053.md) | [23.5](/filings/0001026655-26-000028.md) | [12.1](/filings/0001026655-26-000053.md) |
| Current assets | $m | [102](/filings/0001026655-23-000188.md) | [103](/filings/0001026655-25-000005.md) | [103](/filings/0001026655-24-000059.md) | [119](/filings/0001026655-24-000097.md) | [115](/filings/0001026655-24-000132.md) | [103](/filings/0001026655-26-000009.md) | [116](/filings/0001026655-25-000030.md) | [113](/filings/0001026655-25-000071.md) | [112](/filings/0001026655-25-000085.md) | [103](/filings/0001026655-26-000053.md) | [117](/filings/0001026655-26-000028.md) | [96.3](/filings/0001026655-26-000053.md) |
| Total assets | $m | [217](/filings/0001026655-23-000188.md) | [213](/filings/0001026655-25-000005.md) | [212](/filings/0001026655-24-000059.md) | [226](/filings/0001026655-24-000097.md) | [221](/filings/0001026655-24-000132.md) | [210](/filings/0001026655-26-000009.md) | [224](/filings/0001026655-25-000030.md) | [220](/filings/0001026655-25-000071.md) | [220](/filings/0001026655-25-000085.md) | [228](/filings/0001026655-26-000053.md) | [242](/filings/0001026655-26-000028.md) | [227](/filings/0001026655-26-000053.md) |
| Current liabilities | $m | [52.9](/filings/0001026655-23-000188.md) | [46.2](/filings/0001026655-25-000005.md) | [42.2](/filings/0001026655-24-000059.md) | [52.0](/filings/0001026655-24-000097.md) | [47.9](/filings/0001026655-24-000132.md) | [36.7](/filings/0001026655-26-000009.md) | [46.3](/filings/0001026655-25-000030.md) | [39.7](/filings/0001026655-25-000071.md) | [38.4](/filings/0001026655-25-000085.md) | [34.2](/filings/0001026655-26-000053.md) | [48.5](/filings/0001026655-26-000028.md) | [48.2](/filings/0001026655-26-000053.md) |
| Total liabilities | $m | [82.7](/filings/0001026655-23-000188.md) | [74.4](/filings/0001026655-25-000005.md) | [69.5](/filings/0001026655-24-000059.md) | [78.2](/filings/0001026655-24-000097.md) | [72.8](/filings/0001026655-24-000132.md) | [62.2](/filings/0001026655-26-000009.md) | [73.7](/filings/0001026655-25-000030.md) | [66.5](/filings/0001026655-25-000071.md) | [64.3](/filings/0001026655-25-000085.md) | [70.0](/filings/0001026655-26-000053.md) | [84.1](/filings/0001026655-26-000028.md) | [66.3](/filings/0001026655-26-000053.md) |
| Long-term debt | $m | [22.0](/filings/0001026655-23-000188.md) | [21.5](/filings/0001026655-25-000005.md) | [21.1](/filings/0001026655-24-000059.md) | [20.6](/filings/0001026655-24-000097.md) | [20.2](/filings/0001026655-24-000132.md) | [19.7](/filings/0001026655-26-000009.md) | [19.2](/filings/0001026655-25-000030.md) | [18.8](/filings/0001026655-25-000071.md) | [18.2](/filings/0001026655-25-000085.md) | [17.6](/filings/0001026655-26-000053.md) | [17.0](/filings/0001026655-26-000028.md) | [0.0](/filings/0001026655-26-000053.md) |
| Current portion of debt | $m | [1.3](/filings/0001026655-23-000188.md) | [1.5](/filings/0001026655-25-000005.md) | [1.6](/filings/0001026655-24-000059.md) | [1.8](/filings/0001026655-24-000097.md) | [1.8](/filings/0001026655-24-000132.md) | [1.8](/filings/0001026655-26-000009.md) | [1.8](/filings/0001026655-25-000030.md) | [1.8](/filings/0001026655-25-000071.md) | [1.9](/filings/0001026655-25-000085.md) | [2.1](/filings/0001026655-26-000053.md) | [2.2](/filings/0001026655-26-000028.md) | [0.0](/filings/0001026655-26-000053.md) |
| Shareholders' equity | $m | [134](/filings/0001026655-24-000132.md) | [139](/filings/0001026655-26-000009.md) | [143](/filings/0001026655-25-000071.md) | [148](/filings/0001026655-25-000085.md) | [148](/filings/0001026655-25-000085.md) | [147](/filings/0001026655-26-000053.md) | [150](/filings/0001026655-26-000053.md) | [153](/filings/0001026655-26-000053.md) | [155](/filings/0001026655-25-000085.md) | [158](/filings/0001026655-26-000053.md) | [158](/filings/0001026655-26-000053.md) | [161](/filings/0001026655-26-000053.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [7.2 d](/filings/0001026655-24-000132.md) | [8.7 d](/filings/0001026655-26-000009.md) | [5.1](/filings/0001026655-25-000030.md) | [15.9 d](/filings/0001026655-25-000071.md) | [9.2 d](/filings/0001026655-25-000085.md) | [5.0 d](/filings/0001026655-26-000009.md) | [6.1](/filings/0001026655-26-000028.md) | [3.5 d](/filings/0001026655-26-000053.md) | [4.6 d](/filings/0001026655-25-000085.md) | [5.0 d](/filings/0001026655-26-000009.md) | [(9.2)](/filings/0001026655-26-000028.md) | [16.3 d](/filings/0001026655-26-000053.md) |
| Capital expenditure | $m | [2.3 d](/filings/0001026655-24-000132.md) | [2.3 d](/filings/0001026655-26-000009.md) | [1.9](/filings/0001026655-25-000030.md) | [2.9 d](/filings/0001026655-25-000071.md) | [2.2 d](/filings/0001026655-25-000085.md) | [4.5 d](/filings/0001026655-26-000009.md) | [1.8](/filings/0001026655-26-000028.md) | [2.6 d](/filings/0001026655-26-000053.md) | [4.9 d](/filings/0001026655-25-000085.md) | [8.0 d](/filings/0001026655-26-000009.md) | [3.8](/filings/0001026655-26-000028.md) | [8.3 d](/filings/0001026655-26-000053.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | [0.8 d](/filings/0001026655-24-000132.md) | [(2.7) d](/filings/0001026655-26-000009.md) | [0.0](/filings/0001026655-25-000030.md) | [1.4 d](/filings/0001026655-25-000071.md) | [0.0 d](/filings/0001026655-25-000085.md) | [1.5 d](/filings/0001026655-26-000009.md) | [0.9](/filings/0001026655-26-000028.md) | [(0.3) d](/filings/0001026655-26-000053.md) | [0.0 d](/filings/0001026655-25-000085.md) | [2.6 d](/filings/0001026655-26-000009.md) | [0.5](/filings/0001026655-26-000028.md) | [0.2 d](/filings/0001026655-26-000053.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [8,418](/filings/0001026655-23-000188.md) | [8,752](/filings/0001026655-24-000059.md) | [8,630](/filings/0001026655-24-000097.md) | [8,842](/filings/0001026655-24-000132.md) | [8,832](/filings/0001026655-25-000030.md) | [8,773](/filings/0001026655-25-000071.md) | [8,793](/filings/0001026655-25-000085.md) | [8,816](/filings/0001026655-26-000028.md) | [8,620](/filings/0001026655-26-000053.md) | [8,688](/filings/0001026655-25-000085.md) | [8,766](/filings/0001026655-26-000028.md) | [8,709](/filings/0001026655-26-000053.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 8,849,034 at 2026-08-03, from the cover of the [10-Q filed 2026-08-04](/filings/0001026655-26-000053.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:30 ET. No prices; not investment advice.